Immuno-Oncology: Global Market Forecast and U.S. Real World Data Trends for Immune Checkpoint Inhibitors
DRG’s Khurram Nawaz, Director, Oncology, will be presenting at this year’s Bio Korea 2018.
U.S. Immuno-Oncology: Global Market Forecast and U.S. Real World Data Trends for Immune Checkpoint Inhibitors
May 9, 2018 14:00-15:20
Immuno-oncology has reinvigorated the entire oncology field and transformed the management of a wide range of cancers. Most notably, immune checkpoint inhibitors and CAR T-cell therapies are at the forefront of this clinical revolution. Decision Resources Group keeps a finger on the pulse of the immuno-oncology landscape by blending market research data, comprehensive real-world data capabilities, and in-house oncology expertise. Drawing on our rich array of information, data, and insights, this presentation covers key commercial trends affecting the global market for immune checkpoint inhibitors, and puts the spotlight on U.S. claims data to uncover shifting dynamics in their uptake in the United States. We also touch on the clinical and commercial potential for CAR T-cell therapies.
Don’t miss our presentation! Access the full schedule here.
To arrange a meeting with one of our experts, please contact us
We look forward to seeing you at Bio Korea!